Table 2 Main and interactive effects of amyloid-PET and APOEε4 on tau-PET uptake and CSF p-tau.
From: APOEε4 potentiates the relationship between amyloid-β and tau pathologies
(A) TRIAD tau-PET cohort | ||||
---|---|---|---|---|
Brain region | Amyloid-PET main effect β estimate (SE) | APOE4 main effect β estimate (SE) | Total of amyloid-PET main effect β estimate and APOE4 main effect β estimate | Amyloid-PET × APOE4 interaction effect β estimate (SE) |
Posterior cingulate | 0.19 (0.1) | 0.02 (0.09) | 0.17 | 0.26 (0.15) |
Precuneus | 0.13 (0.11) | −0.03 (0.09) | 0.10 | 0.23 (0.14) |
Inferior parietal | 0.29 (0.1) | −0.07 (0.09) | 0.22 | 0.23 (0.14) |
Medial prefrontal | 0.20 (0.08) | −0.04 (0.07) | 0.16 | 0.25 (0.13) |
Occipital | 0.25 (0.07) | −0.02 (0.07) | 0.23 | 0.41 (0.1) |
(B) ADNI tau-PET cohort | ||||
---|---|---|---|---|
Brain region | Amyloid-PET main effect β estimate (SE) | Single APOE4 Main Effect β Estimate (SE) | Total of amyloid-PET main effect β estimate and single APOE4 main effect β estimate | Amyloid-PET × Single APOE4 interaction effect β estimate (SE) |
Posterior cingulate | 0.16 (0.05) | −0.04 (0.03) | 0.12 | 0.28 (0.1) |
Lateral temporal | 0.37 (0.06) | −0.03 (0.03) | 0.33 | 0.36 (0.11) |
Inferior parietal | 0.21 (0.05) | −0.02 (0.04) | 0.19 | 0.29 (0.11) |
Orbitofrontal | 0.18 (0.05) | −0.04 (0.03) | 0.14 | 0.24 (0.08) |
Temporooccipital | 0.21 (0.06) | −0.01 (0.04) | 0.20 | 0.44 (0.11) |
(C) ADNI tau-PET cohort | ||||
---|---|---|---|---|
Brain region | Amyloid-PET main effect β estimate (SE) | Double APOE4 main effect β estimate (SE) | Total of amyloid-PET main effect β estimate and double APOE4 main effect β estimate | Amyloid-PET × Double APOE4 interaction effect β estimate (SE) |
Posterior cingulate | 0.21 (0.05) | −0.07 (0.06) | 0.14 | 0.39 (0.13) |
Lateral temporal | 0.24 (0.05) | −0.001 (0.06) | 0.24 | 0.49 (0.15) |
Inferior parietal | 0.18 (0.04) | 0.006 (0.07) | 0.17 | 0.48 (0.15) |
Medial prefrontal | 0.19 (0.05) | −0.07 (0.05) | 0.12 | 0.38 (0.11) |
Occipital | 0.2 (0.05) | −0.01 (0.05) | 0.19 | 0.39 (0.12) |
Orbitofrontal | 0.24 (0.04) | −0.06 (0.05) | 0.18 | 0.48 (0.14) |
Dorsolateral prefrontal | 0.15 (0.04) | −0.01 (0.06) | 0.14 | 0.43 (0.13) |
(D) ADNI lumbar puncture cohort | ||||
---|---|---|---|---|
Amyloid-PET main effect β estimate (SE) | Single APOE4 main effect β estimate (SE) | Total of amyloid-PET main effect β estimate and single APOE4 main effect β estimate | Amyloid-PET × Single APOE4 interaction effect β estimate (SE) | |
CSF p-tau | 14.81 (3.53) | 3.94 (1.28) | 18.75 | 20.31 (6.59) |
(E) ADNI lumbar puncture cohort | ||||
---|---|---|---|---|
Amyloid-PET main effect β estimate (SE) | Double APOE4 main effect β estimate (SE) | Total of amyloid-PET main effect β estimate and double APOE4 main effect β estimate | Amyloid-PET × Double APOE4 interaction effect β estimate (SE) | |
CSF p-tau | 14.81 (3.53) | 3.87 (2.55) | 18.68 | 33.01 (14.24) |